SCHEMBL6629341

SCHEMBL6629341

CCOC(=O)c1cccc(NC(=O)OCc2c[nH]c(Cc3cc4nc(C(=O)OCC)c(OCC)nc4cc3[N+](=O)[O-])n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
SMN1; SMN2 Q16637 6/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
POLB P06746 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
ABCB1 P08183 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6631139 0.92 ALDH1A1 (0.40) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL6602436 0.79 ALDH1A1 (0.41) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL6603581 0.77 GRIA1 (0.55)
SCHEMBL6603788 0.76 ALDH1A1 (0.38) MAPTSMN1; SMN2HPGDKMT2AMEN1
SCHEMBL6603385 0.76 KMT2A (0.40) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL6602557 0.76 KMT2A (0.38) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL6601960 0.75 KMT2A (0.41) MAPTSMN1; SMN2HPGDKMT2AMEN1
SCHEMBL6604288 0.70 GRIA1 (0.46) MAPTSMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL6382753 0.70 NAMPT (0.43) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL6603403 0.69 MAPT (0.32) MAPTCYP1A2SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed